The chemical class known as PATE4 Activators encompasses a range of compounds that can activate the prostate and testis expressed protein 4 (PATE4), a protein implicated in male fertility and reproductive biology. These activators are not a homogenous group but rather a collection of diverse chemicals that can influence the activity of PATE4 through various biochemical pathways and cellular processes. The mechanisms by which these activators operate involve modulation of intracellular signaling cascades, alteration of gene expression, and changes in the cellular ionic environment, all of which can lead to the activation of PATE4. For instance, some activators work by increasing the levels of secondary messengers such as cyclic AMP (cAMP), which in turn can activate key protein kinases that phosphorylate target proteins, including those in the PATE family. This phosphorylation can affect the function of PATE4 by altering its interaction with other proteins or its localization within the cell.
Moreover, the regulation of PATE4 activity by these activators can be linked to the maintenance of reproductive tissue integrity and sperm functionality. The activators can affect the expression of PATE4 by engaging with the transcription machinery or by influencing the stability and translation of its mRNA. Changes in the ionic composition of the cellular milieu, such as alterations in calcium or zinc concentrations, can also modulate the activity of PATE4. These ions play critical roles in cellular signaling and are particularly important in the context of sperm maturation and the acrosome reaction during fertilization. By affecting these ions, the activators can indirectly influence the activity of PATE4. Furthermore, the interaction of these activators with hormone signaling pathways provides another avenue for modulating PATE4 activity, as hormonal signals are key regulators of reproductive function and protein expression in reproductive tissues. Overall, the activation of PATE4 by this eclectic group of chemicals is complex and multifaceted, relying on a network of cellular signals and conditions to exert its influence on reproductive biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases to increase cAMP and cGMP levels, which could activate PATE4. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Essential for sperm function; could activate PATE4 by altering the ionic environment of reproductive tissues. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in gene transcription regulation; could activate PATE4 by modulating transcription factors. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor, which could activate PATE4 by influencing cell signaling pathways. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Could activate PATE4 by regulating expression or function via estrogen receptor signaling pathways. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Inhibits PDE5, raising cGMP levels, which could activate PATE4 similarly to sildenafil. | ||||||
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $141.00 $408.00 | ||
Could activate PATE4 by altering endocrine signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA; could activate PATE4 through phosphorylation events or changes in gene expression. | ||||||